Perceptive Advisors LLC 13D and 13G filings for ADMA Biologics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 4:49 pm Sale | 2023-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 6,433,369 2.800% | -5,466,886 (-45.94%) | Filing |
| 2023-02-14 2:31 pm Sale | 2022-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 11,900,255 5.400% | -33,132 (-0.28%) | Filing |
| 2022-02-14 8:55 pm Unchanged | 2021-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 11,933,387 6.100% | 0 (Unchanged) | Filing |
| 2021-10-27 09:16 am Sale | 2021-10-22 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 11,933,387 6.600% | -4,651,415 (-28.05%) | Filing |
| 2021-02-16 3:37 pm Purchase | 2020-12-31 | 13G | ADMA Biologics, Inc. ADMA | Perceptive Advisors LLC | 16,584,802 17.500% | 500,000 (+3.11%) | Filing |